What's new

Human medicines European public assessment report (EPAR): Uptravi, selexipag, Date of authorisation: 12/05/2016, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Uptravi, selexipag, Date of authorisation: 12/05/2016, Revision: 17, Status: Authorised

Mar 17, 2025 - 15:42
 0
Human medicines European public assessment report (EPAR): Uptravi, selexipag, Date of authorisation: 12/05/2016, Revision: 17, Status: Authorised
Human medicines European public assessment report (EPAR): Uptravi, selexipag, Date of authorisation: 12/05/2016, Revision: 17, Status: Authorised
Read More

Tags:

Previous Article

These Are The Used Cars You Would Buy With $10,000

Next Article

FERC reaffirms approval of Southeastern SEEM market

Related Posts

Clinical Trials Information System (CTIS) bitesize talk: End of transition period and notifications including serious breach, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 16 October 2024, 15:30 (CEST) to 16 October 2024, 17:00 (CEST)

Clinical Trials Information System (CTIS) bitesize talk...

Mar 3, 2025  0

Human medicines European public assessment report (EPAR): Advagraf, tacrolimus, Date of authorisation: 23/04/2007, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0

Changing the labelling and package leaflet (Article 61(3) notifications)

Changing the labelling and package leaflet (Article 61(...

Feb 18, 2025  0